Zhu HD, Fan WJ, Zhao C, Wang S, et al. Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial. J Clin Oncol 2026 Feb 24:JCO2501796. doi: 10.1200/JCO-25-01796.
PMID: 41734362